"If everyone is moving forward together,

then sucess takes care of itself"

Henry Ford


Natural surfactant for prevention and treatment of IRDS

Natural surfactant for the treatment of RDS

Active ingredient

- Phospholipid fraction from bovine lungs


- Prevention of respiratory distress syndrome (RDS) in premature infants

- Treatment of infantile respiratory distress syndrome (IRDS)

Pharmaceutical form and presentations

- Lyophilized phospholipids in vials with 50 mg and 100 mg

- Syringe with solvent for reconstitution


- Intratracheal instillation

Special feature

- Storage at room temperature

Produced in

- European Union

Available countries

- On request


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.

Diese Website verwendet ausschließlich technisch notwendige Cookies. Read more …